Seth Klarman Takeda Pharmaceutical CO LTD Transaction History

Baupost Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$16.88 - $20.83 $159 Million - $197 Million	-9,434,803 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $51,679 - $57,567	-3,200 Reduced 0.03%	9,434,803 $162 Million
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $20.4 Million - $25.2 Million	-1,231,018 Reduced 11.54%	9,438,003 $167 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $178 Million - $230 Million	10,669,021 New	10,669,021 $217 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.